SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-084873
Filing Date
2008-04-18
Accepted
2008-04-18 16:58:28
Documents
3
Period of Report
2008-04-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15418
2 PRESS RELEASE dex991.htm EX-99.1 8574
3 GRAPHIC g29157img001.jpg GRAPHIC 2011
  Complete submission text file 0001193125-08-084873.txt   28497
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 08765090
SIC: 2834 Pharmaceutical Preparations